PortfoliosLab logoPortfoliosLab logo
AZN vs. CAH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

AZN vs. CAH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AstraZeneca PLC (AZN) and Cardinal Health, Inc. (CAH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, AZN achieves a -4.86% return, which is significantly lower than CAH's 11.28% return. Over the past 10 years, AZN has underperformed CAH with an annualized return of 13.01%, while CAH has yielded a comparatively higher 13.79% annualized return.


AZN

1D
-1.13%
1M
-9.64%
6M
-5.54%
YTD
-4.86%
1Y
14.99%
3Y*
8.61%
5Y*
10.93%
10Y*
13.01%
ALL TIME*
12.67%

CAH

1D
-0.89%
1M
-4.21%
6M
7.99%
YTD
11.28%
1Y
45.30%
3Y*
37.51%
5Y*
33.65%
10Y*
13.79%
ALL TIME*
17.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$437.01M$502.71M$405.86M
$436.04M$522.82M$516.64M

AZN vs. CAH - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
AZN
AstraZeneca PLC
-4.86%43.30%-0.62%1.44%19.14%19.66%3.12%35.68%13.86%33.10%
CAH
Cardinal Health, Inc.
11.28%76.25%19.01%34.15%54.08%-0.40%10.09%18.04%-24.50%-12.65%

Correlation

The correlation between AZN and CAH is 0.35, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.35

Correlation (3Y)
Balances recent behavior with more history.

0.24

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.25

Correlation (10Y)
Provides a long-term view across more market conditions.

0.25

Correlation (All Time)
Calculated using the full available price history since May 17, 1993

0.26

The correlation between AZN and CAH shifts across timeframes, from 0.24 (3 years) to 0.35 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

AZN:

$132.79B

CAH:

$53.18B

EPS

AZN:

$13.34

CAH:

$6.57

PE Ratio

AZN:

12.84

CAH:

34.57

PEG Ratio

AZN:

0.02

CAH:

0.82

PS Ratio

AZN:

2.19

CAH:

0.22

Total Revenue (TTM)

AZN:

$61.18B

CAH:

$250.55B

Gross Profit (TTM)

AZN:

$48.56B

CAH:

$9.23B

EBITDA (TTM)

AZN:

$20.49B

CAH:

$2.79B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

AZN vs. CAH — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

AZN
AZN Risk / Return Rank: 6262
Overall Rank
AZN Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
AZN Sortino Ratio Rank: 6060
Sortino Ratio Rank
AZN Omega Ratio Rank: 5858
Omega Ratio Rank
AZN Calmar Ratio Rank: 6363
Calmar Ratio Rank
AZN Martin Ratio Rank: 6565
Martin Ratio Rank

CAH
CAH Risk / Return Rank: 8585
Overall Rank
CAH Sharpe Ratio Rank: 8686
Sharpe Ratio Rank
CAH Sortino Ratio Rank: 8686
Sortino Ratio Rank
CAH Omega Ratio Rank: 8787
Omega Ratio Rank
CAH Calmar Ratio Rank: 8282
Calmar Ratio Rank
CAH Martin Ratio Rank: 8585
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

AZN vs. CAH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for AstraZeneca PLC (AZN) and Cardinal Health, Inc. (CAH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


AZNCAHDifference
Sharpe ratioReturn per unit of total volatility

-0.94

Sortino ratioReturn per unit of downside risk

-1.35

Omega ratioGain probability vs. loss probability

1.12

1.31

-0.19

Calmar ratioReturn relative to maximum drawdown

0.72

2.23

-1.51

Martin ratioReturn relative to average drawdown

1.91

6.78

-4.87

AZN vs. CAH - Sharpe Ratio Comparison

The current AZN Sharpe Ratio is 0.56, which is lower than the CAH Sharpe Ratio of 1.49. The chart below compares the historical Sharpe Ratios of AZN and CAH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

AZN vs. CAH - Drawdown Comparison

The maximum AZN drawdown since its inception was -48.94%, smaller than the maximum CAH drawdown of -61.93%. Use the drawdown chart below to compare losses from any high point for AZN and CAH.


Loading charts...

Drawdown Indicators


AZNCAHDifference

Max Drawdown

Largest peak-to-trough decline

-48.94%

-61.93%

+12.99%

Max Drawdown (1Y)

Largest decline over 1 year

-21.08%

-20.42%

-0.66%

Max Drawdown (3Y)

Largest decline over 3 years

-27.87%

-20.42%

-7.45%

Max Drawdown (5Y)

Largest decline over 5 years

-27.87%

-22.34%

-5.53%

Max Drawdown (10Y)

Largest decline over 10 years

-27.87%

-46.13%

+18.26%

Current Drawdown

Current decline from peak

-17.80%

-5.27%

-12.53%

Average Drawdown

Average peak-to-trough decline

-11.38%

-15.89%

+4.51%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.91%

6.70%

+1.21%

Volatility

AZN vs. CAH - Volatility Comparison

AstraZeneca PLC (AZN) has a higher volatility of 12.13% compared to Cardinal Health, Inc. (CAH) at 6.32%. This indicates that AZN's price experiences larger fluctuations and is considered to be riskier than CAH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


AZNCAHDifference

Volatility (1M)

Calculated over the trailing 1-month period

12.13%

6.32%

+5.81%

Volatility (6M)

Calculated over the trailing 6-month period

20.07%

20.76%

-0.69%

Volatility (1Y)

Calculated over the trailing 1-year period

27.44%

30.46%

-3.02%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

24.51%

25.34%

-0.83%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

24.95%

29.27%

-4.32%

Dividends

AZN vs. CAH - Dividend Comparison

AZN's dividend yield for the trailing twelve months is around 3.11%, more than CAH's 0.90% yield.


PositionTTM20252024202320222021202020192018201720162015
AZN
AstraZeneca PLC
3.11%1.70%2.27%2.15%2.12%2.35%2.80%2.81%3.69%3.95%5.01%4.06%
CAH
Cardinal Health, Inc.
0.90%0.99%1.28%1.98%2.57%3.80%3.62%3.80%4.24%3.00%2.41%1.68%

Financials

AZN vs. CAH - Financials Comparison

This section allows you to compare key financial metrics between AstraZeneca PLC and Cardinal Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

AZN vs. CAH - Profitability Comparison

The chart below illustrates the profitability comparison between AstraZeneca PLC and Cardinal Health, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

AZN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, AstraZeneca PLC reported a gross profit of 11.18B and revenue of 15.19B. Therefore, the gross margin over that period was 73.6%.

CAH - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jul 2026, Cardinal Health, Inc. reported a gross profit of 2.50B and revenue of 60.94B. Therefore, the gross margin over that period was 4.1%.

AZN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, AstraZeneca PLC reported an operating income of 3.07B and revenue of 15.19B, resulting in an operating margin of 20.2%.

CAH - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jul 2026, Cardinal Health, Inc. reported an operating income of 509.00M and revenue of 60.94B, resulting in an operating margin of 0.8%.

AZN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, AstraZeneca PLC reported a net income of 2.48B and revenue of 15.19B, resulting in a net margin of 16.3%.

CAH - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jul 2026, Cardinal Health, Inc. reported a net income of 399.00M and revenue of 60.94B, resulting in a net margin of 0.7%.


Frequently Asked Questions


AZN and CAH have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

AZN has higher volatility (12.13%) compared to CAH (6.32%). In terms of maximum drawdown, AZN dropped -48.94% vs CAH's -61.93%.

CAH currently has the higher Sharpe Ratio (1.49 vs 0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for AZN and CAH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer